Merck & Co Inc
NYSE: MRK
$117.17
-$0.06 (-0.1%)
Closing Price on September 20, 2024
MRK Articles
Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less volatile and act better than biotechs if the market gets dicey.
Published:
Last Updated:
September 29, 2016: Markets opened slightly higher again Thursday following Wednesday’s announced agreement among OPEC members to rein in production. Comments various Fed officials talking a rate...
Published:
Last Updated:
If there is one trend that has worked in America, it is the trend of betting on the public taking care of their pets. Now Merrill Lynch has issued a report on the state of animal health, with two Buy...
Published:
Last Updated:
September 28, 2016: Markets opened slightly higher again Wednesday and both the S&P 500 and the DJIA dipped below the break-even line before a report from Reuters hit the wires, citing sources...
Published:
Last Updated:
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
Published:
Last Updated:
September 20, 2016: Markets opened higher Tuesday as no sector was showing big gains but healthcare stocks the clear leader. Traders and investors are likely trying to position themselves for the...
Published:
Last Updated:
September 19, 2016: Markets opened higher Monday and while most sectors traded in the green the gains didn’t add up to much. Fresh speculation about an OPEC production freeze pushed oil prices up...
Published:
Last Updated:
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
September 7, 2016: Markets opened mixed Wednesday following largely unmemorable sessions overseas. European markets await a policy statement from the ECB due Thursday morning. The Beige Book’s...
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
August 24, 2016: Markets opened lower Wednesday and only the Nasdaq Composite made even a brief visit to positive territory during the day’s trading session. Healthcare and materials stocks led the...
Published:
Last Updated:
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, nor do we know what price.
Published:
Last Updated:
Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for each of its large cap pharmaceutical stocks.
Published:
Last Updated:
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
Published:
Last Updated: